RBC Capital analyst Frank Morgan raised his price target on Universal Health to $165 after its Q2 earnings beat and a deal reached with the Department of Justice that resolves the government's investigation of the company's behavioral health care facilities. With the overhang eliminated, the analyst contends that the bias for Universal Health Services' FY19 performance is now to the upside, keeping his Outperform rating on the stock.
Barclays analyst Andrew Mok raised the firm's price target on Universal Health to $189 from $181 and keeps an Equal Weight rating on the shares post the Q1 report. The company posted broad pricing strength and strong acute inpatient volumes, which drove a big EBITDA beat, the analyst tells investors in a research note.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here